Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease
about
Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan.Prognostic factors for long term survival in patients with advanced non-small cell lung cancer.Correlation of apolipoprotein A-I kinetics with survival and response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer.
P2860
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Second or third additional che ...... patients with advanced disease
@ast
Second or third additional che ...... patients with advanced disease
@en
Second or third additional che ...... patients with advanced disease
@en-gb
Second or third additional che ...... patients with advanced disease
@nl
type
label
Second or third additional che ...... patients with advanced disease
@ast
Second or third additional che ...... patients with advanced disease
@en
Second or third additional che ...... patients with advanced disease
@en-gb
Second or third additional che ...... patients with advanced disease
@nl
prefLabel
Second or third additional che ...... patients with advanced disease
@ast
Second or third additional che ...... patients with advanced disease
@en
Second or third additional che ...... patients with advanced disease
@en-gb
Second or third additional che ...... patients with advanced disease
@nl
P2093
P2860
P50
P1476
Second or third additional che ...... patients with advanced disease
@en
P2093
Catherine Delbaldo
Estelle Rolland
Jean Pierre Pignon
Nathalie Syz
P2860
P356
10.1002/14651858.CD004569.PUB3
P577
2012-04-18T00:00:00Z